Vol. 6, Issue 2, Part C (2024)

The fungal infection known as candidiasis has become a major cause of morbidity and mortality worldwide in recent times, especially in people who are critically ill. The metabolic disease diabetes mellitus (DM), which damages the immune system, increases the risk of candidiasis. The interaction between candidiasis and diabetes, including its biology, causes, symptoms, and management options, is the main topic of this review. Results show that those with poorly managed diabetes are more vulnerable to severe and frequent yeast infections, with uncontrolled hyperglycemia making this vulnerability worse. Furthermore, because some diabetes drugs contain added carbohydrates that encourage the yeast to colonize at harmful levels and there is a relationship between these prescriptions and an increased risk of urogenital candidiasis. Patients with diabetes who have severe candidiasis may experience severe urinary tract infections, during pregnancy, and recurrent infections. These infections frequently result in prolonged hospital stays and increased care expenses, especially when indwelling medical devices are used for longer periods of time. In order to address the rising prevalence of candidiasis among diabetes patients and lessen the growing worldwide burden of these infections, the review emphasizes the urgent need for improved prevention and treatment techniques.